
Congress trades
Catalent, Inc. (CTLT)
NYSE · Healthcare · 36 congress trades · last filed 2 years agono longer trading under this ticker
About Catalent, Inc.
from the company's filings and listing, as of Oct 22, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Chief executive
- -
- Employees
- 17,000
- Listed since
- -
- Market value
- $11.5Blast quoted Dec 17, 2024
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q1 FY2025reported Nov 5, 2024 | -$0.13 | -$0.03 | $1.0B | $1.1B | EPS missRevenue miss |
| Q4 FY2024reported Aug 29, 2024 | $0.65 | $0.47 | $1.3B | $1.2B | EPS beatRevenue beat |
| Q3 FY2024reported May 8, 2024 | -$0.06 | $0.22 | $1.1B | $1.1B | EPS missRevenue miss |
| Q2 FY2024reported Feb 9, 2024 | -$0.24 | -$0.02 | $1.0B | $1.1B | EPS missRevenue miss |
| Q1 FY2024reported Nov 15, 2023 | -$0.10 | -$0.13 | $982.0M | $940.2M | EPS beatRevenue beat |
| Q4 FY2023reported Aug 29, 2023 | $0.09 | $0.10 | $1.1B | $1.1B | EPS missRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Congress trades in CTLT
20 disclosures of 36 on record · median 20d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | May 29, 2024 | Jun 5, 2024 | 7d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Apr 26, 2024 | May 6, 2024 | 10d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | May 19, 2023 | Jun 12, 2023 | 24d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | May 23, 2023 | Jun 12, 2023 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Apr 25, 2023 | May 8, 2023 | 13d |
| Daniel S. Goldman | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Mar 7, 2023 | Apr 17, 2023 | 41d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Mar 24, 2023 | Apr 7, 2023 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Feb 14, 2023 | Mar 3, 2023 | 17d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Nov 30, 2022 | Dec 29, 2022 | 29d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Nov 3, 2022 | Dec 6, 2022 | 33d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | May 5, 2022 | Jun 10, 2022 | 36d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | May 23, 2022 | Jun 10, 2022 | 18d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Jan 21, 2022 | Feb 8, 2022 | 18d |
| Thomas R. Suozzi | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Dec 18, 2020 | Sep 23, 2021 | 279d |
| Thomas R. Suozzi | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Jun 3, 2021 | Sep 23, 2021 | 112d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Sep 29, 2020 | Oct 14, 2020 | 15d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Sep 24, 2020 | Oct 13, 2020 | 19d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Aug 12, 2020 | Sep 20, 2020 | 39d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Aug 17, 2020 | Sep 14, 2020 | 28d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Dec 17, 2024 | Sep 2, 2020 | Sep 14, 2020 | 12d |
We hold no closing prices for any row shown here, so no move is shown. Not investment advice.
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in CTLT, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded CTLT?
Ro Khanna, Daniel S. Goldman, Susie Lee, Thomas R. Suozzi, Gilbert Ray Cisneros, Jr. and Josh Gottheimer disclosed CTLT transactions in the filings shown here.
How quickly are CTLT trades disclosed?
Congressional disclosures took a median of 20 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 27, 2026.
